Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/29/1999WO1999067271A1 Testosterone derivative
12/29/1999WO1999067266A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067264A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067263A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067262A1 Adenosine derivatives
12/29/1999WO1999067261A1 NOVEL COMPOUNDS DERIVED FROM α-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE
12/29/1999WO1999067258A1 Arylsulfonanilide phosphates
12/29/1999WO1999067256A1 Cephem compounds
12/29/1999WO1999067255A1 Propenyl cephalosporin derivatives
12/29/1999WO1999067254A2 Multi-drug resistant retroviral protease inhibitors and use thereof
12/29/1999WO1999067252A2 Epothilone derivatives and their synthesis and use
12/29/1999WO1999067250A1 Syntheses of a variety of lamellarin compounds and analogues
12/29/1999WO1999067249A1 Alkyl ether analogs of chlorins having an n-substituted imide ring
12/29/1999WO1999067245A1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom
12/29/1999WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/29/1999WO1999067243A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
12/29/1999WO1999067242A1 Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
12/29/1999WO1999067241A1 (heterocyclic) methyl substituted carbapenem antibacterials
12/29/1999WO1999067240A1 (heterocyclic)methyl substituted carbapenem antibacterials
12/29/1999WO1999067237A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use
12/29/1999WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
12/29/1999WO1999067235A1 Five-membered ring compounds
12/29/1999WO1999067231A1 Nitrate salts of antihypertensive medicines
12/29/1999WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999WO1999067229A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases
12/29/1999WO1999067221A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999067220A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999067219A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999067216A1 DERIVATIZED POLYMERS OF α-OLEFIN-MALEIC ANHYDRIDE ALKYL HALF-ESTER OR FULL ACID
12/29/1999WO1999067215A1 Amidino and guanidino azetidinone tryptase inhibitors
12/29/1999WO1999067212A2 Active carbon filter as an oxidation inhibitor for prostane derivatives
12/29/1999WO1999067210A1 Stable no-delivering compounds
12/29/1999WO1999067208A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999WO1999067207A1 Naphthalenesulfonamide derivatives and drugs containing the same
12/29/1999WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999WO1999067199A1 2-fluoro-2-alkyl alkanoamides with anticonvulsant activity
12/29/1999WO1999067198A1 Desformoterol and process for its preparation
12/29/1999WO1999067197A1 Benflumetol derivatives, intermediates thereof and their use against parasitical protozoa and trematodes
12/29/1999WO1999066958A2 Use of a compound having affinity for the benzodiazepine mitochondrial receptor in cancer therapy
12/29/1999WO1999066945A1 Compositions and methods for inhibiting bone resorption
12/29/1999WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999WO1999066943A1 Dietary supplement for supporting cerebrovascular tone
12/29/1999WO1999066942A1 Compounds obtained from salvia species having antiviral activity
12/29/1999WO1999066941A1 Herbal extract composition and method with immune-boosting capability
12/29/1999WO1999066936A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
12/29/1999WO1999066935A1 Male contraceptive comprising a prolactin inhibitor and a sex steroid
12/29/1999WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
12/29/1999WO1999066932A1 New use of a pyridazinone derivative
12/29/1999WO1999066931A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action
12/29/1999WO1999066930A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999WO1999066929A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999WO1999066928A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999WO1999066927A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999WO1999066926A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds)
12/29/1999WO1999066925A1 Protease inhibitors
12/29/1999WO1999066924A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
12/29/1999WO1999066923A1 Application for utility patent for improved enriched platelet wound healant
12/29/1999WO1999066922A1 Method of altering nutritional components of milk produced by a lactating animal
12/29/1999WO1999066921A1 Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
12/29/1999WO1999066920A1 The use of valproic acid analog for the treatment and prevention of migraine and affective illness
12/29/1999WO1999066919A1 Pharmaceutical composition containing a salt of acetaminophen and at least one other active ingredient
12/29/1999WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999WO1999066917A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid
12/29/1999WO1999066916A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
12/29/1999WO1999066915A2 Therapeutic applications of estrogenic carboxylic acids
12/29/1999WO1999066914A2 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
12/29/1999WO1999066913A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
12/29/1999WO1999066912A2 Method of treating pulmonary hypertension
12/29/1999WO1999066911A2 Gastro-intestinal adverse effect-free composition comprising an l-carnitine replacement
12/29/1999WO1999066910A2 Agents for specifically inhibiting osteoclastic bone resorption
12/29/1999WO1999066909A2 Method and compositions for the treatment or amelioration of female sexual dysfunction
12/29/1999WO1999066908A1 Matrix-type transdermal patch for steroid hormones
12/29/1999WO1999066907A1 Transdermal therapeutic system containing hormones and crystallization inhibitors
12/29/1999WO1999066903A2 Large porous particles emitted from an inhaler
12/29/1999WO1999066902A1 Injectable pharmaceutical formulations of partricin derivatives
12/29/1999WO1999066901A2 Transdermal therapeutic system containing hormones and crystallization inhibitors
12/29/1999WO1999066900A2 Use of nonoxynol-9 as lubricant and method for its production
12/29/1999WO1999066878A2 Use of bis(diazo) compound as antifungal agents
12/29/1999WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999WO1999066870A1 A device and method for the treatment of erectile dysfunction
12/29/1999WO1999057125A3 Hygromycin a derivatives
12/29/1999WO1999056735A3 Use of antioxidants for the treatment of inflammatory skin diseases
12/29/1999WO1999056698A3 Treatment of celiac disease
12/29/1999WO1999055830A3 Process for synthesizing cox-2 inhibitors
12/29/1999WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
12/29/1999WO1999055305A3 Controlled release peroral compositions of levosimendan
12/29/1999WO1999054326A8 Dihydropyrimidines
12/29/1999WO1999054315A3 Triazolones with a neuroprotective action
12/29/1999WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
12/29/1999WO1999044597A3 Use of macrolide compounds for the treatment of ards
12/29/1999EP0967220A1 Novel arabinosyladenine derivatives
12/29/1999EP0967214A1 Intranasal formulations for treating sexual disorders
12/29/1999EP0967210A1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process
12/29/1999EP0967207A1 Nitrone derivatives, process for their preparation and pharmaceutical compositions containing them
12/29/1999EP0967206A1 Derivatives of N-phenylpyrazoles
12/29/1999EP0967202A1 Photolysis of 7-dehydrocholesterol
12/29/1999EP0967201A1 Pharmaceutical agents containing sulfonamids as matrix metalloproteinase inhibitors
12/29/1999EP0967200A1 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
12/29/1999EP0966974A1 Antibacterial composition for topical administration containing antibiotics
1 ... 6386 6387 6388 6389 6390 6391 6392 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 ... 7860